$6.14
-0.22-3.46%
Last update: Oct 30, 2:20 PM
Bolt Biotherapeutics Inc (BOLT) Stock Price, Quote, News & History
BOLTNASDAQ
You can purchase shares of Bolt Biotherapeutics (NASDAQ:BOLT) through any online brokerage.
Other companies in Bolt Biotherapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Bolt Biotherapeutics has a consensus price target of $28.80.
The stock price for Bolt Biotherapeutics (NASDAQ: BOLT) is $6.14 last updated October 30, 2026 at 2:20 PM EDT.
There are no upcoming dividends for Bolt Biotherapeutics.
Bolt Biotherapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Bolt Biotherapeutics.
Bolt Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company is focused on the clinical development of BDC-4182, its claudin 18.2 ISAC. Its other pipeline programs...
